Schubart, Jane R.
Zare, Amirhossein
Fernandez-de-Castro, Roberto M.
Figueroa, Hector Rosario
Sarel, Ina
Tuchman, Kelly
Esposito, Kaitlyn
Henderson, Fraser C.
von Schwarz, Ernst
Funding for this research was provided by:
Hemostemix Corp.
Article History
Received: 16 June 2023
Accepted: 17 October 2023
First Online: 26 October 2023
Declarations
:
: See IRB from Genetic Alliance #APC01-001, approval date July 25, 2022: “Process for Obtaining Informed Consent- This study will not obtain specific informed consent for this study, as the data have already been collected and this is a retrospective review of those data. Additionally, a majority of the original sample is either deceased, or has moved to new locations, and cannot be reached.” The IRB waived informed consent for data collection for the study.
: N/A.
: JS received funding from Hemostemix for time spent on data analysis/editing; AZ received funding Hemostemix to perform the data abstraction; RF: none; HF: none; IS has stock in Hemostemix and is the Chief Scientific Officer of Hemostemix; KT received funding from Hemostemix for time spent on data analysis/editing; KE has no disclosures; FH has stock in Hemostemix and is the Chief Medical Officer of Hemostemix; and ES has no disclosures.